Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatology | 5 | 2023 | 904 | 1.530 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5722 | 0.750 |
Why?
|
Molluscum Contagiosum | 1 | 2020 | 13 | 0.720 |
Why?
|
Skin Care | 1 | 2020 | 55 | 0.690 |
Why?
|
Drug Eruptions | 2 | 2020 | 329 | 0.690 |
Why?
|
Mongolian Spot | 1 | 2019 | 3 | 0.690 |
Why?
|
Erythema Multiforme | 1 | 2019 | 31 | 0.680 |
Why?
|
Foot Diseases | 1 | 2020 | 146 | 0.650 |
Why?
|
Pemphigus | 1 | 2020 | 115 | 0.640 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2023 | 376 | 0.640 |
Why?
|
Cryoglobulinemia | 1 | 2019 | 84 | 0.640 |
Why?
|
Hospitals, University | 1 | 2020 | 569 | 0.630 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2018 | 35 | 0.630 |
Why?
|
Community-Institutional Relations | 1 | 2020 | 206 | 0.630 |
Why?
|
Internship and Residency | 4 | 2023 | 5810 | 0.580 |
Why?
|
Hemangiosarcoma | 1 | 2019 | 218 | 0.570 |
Why?
|
Phototherapy | 1 | 2019 | 368 | 0.540 |
Why?
|
Pruritus | 1 | 2019 | 364 | 0.540 |
Why?
|
Dermatomyositis | 1 | 2019 | 251 | 0.530 |
Why?
|
Medical Staff, Hospital | 1 | 2019 | 597 | 0.510 |
Why?
|
Carcinoma, Basal Cell | 1 | 2020 | 555 | 0.490 |
Why?
|
Geriatrics | 1 | 2019 | 384 | 0.490 |
Why?
|
Exanthema | 1 | 2019 | 501 | 0.480 |
Why?
|
Trust | 1 | 2019 | 520 | 0.470 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 1026 | 0.470 |
Why?
|
Interleukins | 1 | 2018 | 773 | 0.450 |
Why?
|
Exons | 1 | 2019 | 2383 | 0.440 |
Why?
|
Documentation | 1 | 2019 | 879 | 0.440 |
Why?
|
Lymphoma, B-Cell | 1 | 2019 | 929 | 0.420 |
Why?
|
Radiation Injuries | 1 | 2019 | 1180 | 0.400 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2681 | 0.390 |
Why?
|
Dermatitis, Atopic | 1 | 2018 | 691 | 0.380 |
Why?
|
Vascular Diseases | 1 | 2019 | 1177 | 0.370 |
Why?
|
Curriculum | 2 | 2023 | 3649 | 0.350 |
Why?
|
Skin | 2 | 2020 | 4422 | 0.330 |
Why?
|
Disease Management | 1 | 2019 | 2479 | 0.320 |
Why?
|
Referral and Consultation | 1 | 2020 | 3560 | 0.290 |
Why?
|
Clinical Competence | 2 | 2019 | 4713 | 0.280 |
Why?
|
Students, Medical | 1 | 2019 | 1884 | 0.260 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3829 | 0.260 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4006 | 0.240 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2022 | 42 | 0.210 |
Why?
|
MutS Homolog 2 Protein | 1 | 2023 | 194 | 0.210 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9107 | 0.190 |
Why?
|
Urticaria | 1 | 2022 | 150 | 0.190 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5215 | 0.180 |
Why?
|
Hospitalization | 1 | 2020 | 10628 | 0.180 |
Why?
|
Necrobiotic Xanthogranuloma | 1 | 2020 | 10 | 0.180 |
Why?
|
DNA Mismatch Repair | 1 | 2023 | 427 | 0.170 |
Why?
|
Hospitals, Special | 1 | 2019 | 88 | 0.170 |
Why?
|
History, 18th Century | 1 | 2019 | 207 | 0.160 |
Why?
|
Physician Executives | 1 | 2019 | 131 | 0.160 |
Why?
|
Purpura | 1 | 2019 | 117 | 0.160 |
Why?
|
Paraproteinemias | 1 | 2020 | 246 | 0.140 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2783 | 0.140 |
Why?
|
Interleukin-23 | 1 | 2018 | 191 | 0.140 |
Why?
|
Iatrogenic Disease | 1 | 2020 | 533 | 0.140 |
Why?
|
History, 19th Century | 1 | 2019 | 717 | 0.140 |
Why?
|
GABA Agents | 1 | 2016 | 41 | 0.140 |
Why?
|
Interleukin-13 | 1 | 2018 | 371 | 0.140 |
Why?
|
Efficiency | 1 | 2019 | 475 | 0.130 |
Why?
|
Self Efficacy | 1 | 2020 | 623 | 0.130 |
Why?
|
Interleukin-12 | 1 | 2018 | 580 | 0.130 |
Why?
|
Humans | 19 | 2023 | 752810 | 0.130 |
Why?
|
Efficiency, Organizational | 1 | 2019 | 689 | 0.120 |
Why?
|
Edema | 1 | 2019 | 772 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2018 | 1110 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1821 | 0.120 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13173 | 0.120 |
Why?
|
Locomotion | 1 | 2016 | 382 | 0.110 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2019 | 694 | 0.110 |
Why?
|
Radiotherapy | 1 | 2019 | 1507 | 0.100 |
Why?
|
Interleukin-17 | 1 | 2018 | 886 | 0.100 |
Why?
|
Teaching | 1 | 2019 | 1159 | 0.100 |
Why?
|
Fatigue | 1 | 2019 | 1523 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2019 | 1178 | 0.090 |
Why?
|
Motor Neurons | 1 | 2016 | 849 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 21810 | 0.090 |
Why?
|
Central Nervous System Neoplasms | 1 | 2019 | 906 | 0.090 |
Why?
|
Skin Diseases | 1 | 2019 | 1081 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2022 | 2127 | 0.090 |
Why?
|
Male | 8 | 2023 | 355160 | 0.080 |
Why?
|
Child, Preschool | 3 | 2020 | 41656 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2020 | 79160 | 0.080 |
Why?
|
Palliative Care | 1 | 2023 | 3578 | 0.070 |
Why?
|
Aged | 5 | 2020 | 166705 | 0.070 |
Why?
|
Female | 8 | 2020 | 386339 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9235 | 0.070 |
Why?
|
Caenorhabditis elegans | 1 | 2016 | 1423 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8706 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 3933 | 0.060 |
Why?
|
Young Adult | 3 | 2020 | 57732 | 0.060 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58347 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 25540 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18302 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17650 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35673 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11603 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39885 | 0.040 |
Why?
|
Oximes | 1 | 2019 | 309 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2019 | 380 | 0.030 |
Why?
|
Child | 2 | 2020 | 78996 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 86822 | 0.030 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2016 | 202 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 766 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 73418 | 0.030 |
Why?
|
Imidazoles | 1 | 2019 | 1173 | 0.030 |
Why?
|
United States | 1 | 2019 | 71434 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2464 | 0.020 |
Why?
|
Middle Aged | 2 | 2020 | 217250 | 0.020 |
Why?
|
Adult | 2 | 2019 | 217168 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8449 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5118 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29369 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39089 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40996 | 0.010 |
Why?
|
Animals | 1 | 2016 | 166825 | 0.000 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_